Cutaneous reactions with enfortumab vedotin: A case series and review of the literature

JAAD Case Rep. 2021 Jun 4:14:7-9. doi: 10.1016/j.jdcr.2021.05.020. eCollection 2021 Aug.

Authors

Allison S Dobry¹, Cesar Antonio Virgen², Anna-Marie Hosking¹, Nataliya Mar³, Linda Doan¹, Bonnie Lee¹, Janellen Smith¹

Affiliations

¹ Department of Dermatology, University of California, Irvine, California.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Division of Hematology/Oncology, University of California, Irvine, California.

No abstract available

Keywords: ADC, antibody-drug conjugate; EV, enfortumab vedotin; drug eruption; drug reaction; enfortumab vedotin; oncologic therapy; oncology.

Publication types

Case Reports